Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

2.

Medical and Surgical Treatment Options for Nonalcoholic Steatohepatitis.

Corey KE, Rinella ME.

Dig Dis Sci. 2016 May;61(5):1387-97. doi: 10.1007/s10620-016-4083-8. Epub 2016 Mar 4. Review.

PMID:
26942734
3.

Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trial.

Lin SC, Ang B, Hernandez C, Bettencourt R, Jain R, Salotti J, Richards L, Kono Y, Bhatt A, Aryafar H, Lin GY, Valasek MA, Sirlin CB, Brouha S, Loomba R.

Therap Adv Gastroenterol. 2016 Mar;9(2):152-61. doi: 10.1177/1756283X15621232.

4.

Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studies.

Pladevall M, Riera-Guardia N, Margulis AV, Varas-Lorenzo C, Calingaert B, Perez-Gutthann S.

BMC Cardiovasc Disord. 2016 Jan 15;16:14. doi: 10.1186/s12872-016-0187-5.

5.

The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice.

Honda Y, Imajo K, Kato T, Kessoku T, Ogawa Y, Tomeno W, Kato S, Mawatari H, Fujita K, Yoneda M, Saito S, Nakajima A.

PLoS One. 2016 Jan 5;11(1):e0146337. doi: 10.1371/journal.pone.0146337. eCollection 2016.

6.

PPARs: Protectors or Opponents of Myocardial Function?

Pol CJ, Lieu M, Drosatos K.

PPAR Res. 2015;2015:835985. doi: 10.1155/2015/835985. Epub 2015 Dec 2. Review.

7.

Chinese Herbal Medicine Treatment Improves the Overall Survival Rate of Individuals with Hypertension among Type 2 Diabetes Patients and Modulates In Vitro Smooth Muscle Cell Contractility.

Lin YJ, Ho TJ, Yeh YC, Cheng CF, Shiao YT, Wang CB, Chien WK, Chen JH, Liu X, Tsang H, Lin TH, Liao CC, Huang SM, Li JP, Lin CW, Pang HY, Lin JG, Lan YC, Liu YH, Chen SY, Tsai FJ, Liang WM.

PLoS One. 2015 Dec 23;10(12):e0145109. doi: 10.1371/journal.pone.0145109. eCollection 2015.

8.

Protective effect of pioglitazone on cardiomyocyte apoptosis in low-dose streptozotocin & high-fat diet-induced type-2 diabetes in rats.

Bhandari U, Kumar V, Kumar P, Tripathi CD, Khanna G.

Indian J Med Res. 2015 Nov;142(5):598-605. doi: 10.4103/0971-5916.171290.

9.
10.

Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?

Górriz JL, Nieto J, Navarro-González JF, Molina P, Martínez-Castelao A, Pallardó LM.

J Clin Med. 2015 Oct 23;4(10):1866-89. doi: 10.3390/jcm4101866. Review.

11.

Metformin and Myocardial Injury in Patients With Diabetes and ST-Segment Elevation Myocardial Infarction: A Propensity Score Matched Analysis.

Basnet S, Kozikowski A, Makaryus AN, Pekmezaris R, Zeltser R, Akerman M, Lesser M, Wolf-Klein G.

J Am Heart Assoc. 2015 Oct 22;4(10):e002314. doi: 10.1161/JAHA.115.002314.

12.

Impact of Insulin Resistance on Neointimal Tissue Proliferation after 2nd-Generation Drug-Eluting Stent Implantation.

Komatsu T, Yaguchi I, Komatsu S, Nakahara S, Kobayashi S, Sakai Y, Taguchi I.

Tex Heart Inst J. 2015 Aug 1;42(4):327-32. doi: 10.14503/THIJ-14-4393. eCollection 2015 Aug.

13.

Trends in Antihyperglycemic Medication Prescriptions and Hypoglycemia in Older Adults: 2002-2013.

Clemens KK, Shariff S, Liu K, Hramiak I, Mahon JL, McArthur E, Garg AX.

PLoS One. 2015 Sep 3;10(9):e0137596. doi: 10.1371/journal.pone.0137596. eCollection 2015.

14.

Comparative analysis of therapeutic efficiency and costs (experience in Bulgaria) of oral antidiabetic therapies based on glitazones and gliptins.

Filipova EP, Uzunova KH, Vekov TY.

Diabetol Metab Syndr. 2015 Jul 16;7:63. doi: 10.1186/s13098-015-0059-7. eCollection 2015.

15.

Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.

Spengler EK, Loomba R.

Mayo Clin Proc. 2015 Sep;90(9):1233-46. doi: 10.1016/j.mayocp.2015.06.013. Epub 2015 Jul 26. Review.

PMID:
26219858
16.

Variation in Association Between Thiazolidinediones and Heart Failure Across Ethnic Groups: Retrospective analysis of Large Healthcare Claims Databases in Six Countries.

Roughead EE, Chan EW, Choi NK, Kimura M, Kimura T, Kubota K, Lai EC, Man KK, Nguyen TA, Ooba N, Park BJ, Sato T, Shin JY, Wang T, Griffiths J, Wong IC, Yang YH, Pratt NL.

Drug Saf. 2015 Sep;38(9):823-31. doi: 10.1007/s40264-015-0318-4.

17.

Triglyceride High-Density Lipoprotein Ratios Predict Glycemia-Lowering in Response to Insulin Sensitizing Drugs in Type 2 Diabetes: A Post Hoc Analysis of the BARI 2D.

Zonszein J, Lombardero M, Ismail-Beigi F, Palumbo P, Foucher S, Groenewoud Y, Cushing G, Wajchenberg B, Genuth S; Bari 2D Study Group.

J Diabetes Res. 2015;2015:129891. doi: 10.1155/2015/129891. Epub 2015 May 27.

18.

Cardiovascular Risk in Diabetes Mellitus: Complication of the Disease or of Antihyperglycemic Medications.

Alvarez CA, Lingvay I, Vuylsteke V, Koffarnus RL, McGuire DK.

Clin Pharmacol Ther. 2015 Aug;98(2):145-61. doi: 10.1002/cpt.143. Epub 2015 Jul 3. Review.

PMID:
25963811
19.

Pioglitazone treatment increases survival and prevents body weight loss in tumor-bearing animals: possible anti-cachectic effect.

Beluzi M, Peres SB, Henriques FS, Sertié RA, Franco FO, Santos KB, Knobl P, Andreotti S, Shida CS, Neves RX, Farmer SR, Seelaender M, Lima FB, Batista ML Jr.

PLoS One. 2015 Mar 25;10(3):e0122660. doi: 10.1371/journal.pone.0122660. eCollection 2015.

20.

Promoting effect of triterpenoid compound from Agrimonia pilosa Ledeb on preadipocytes differentiation via up-regulation of PPARγ expression.

Guo T, Zhu L, Tan J, Zhou X, Xiao L, Liu X, Wang B.

Pharmacogn Mag. 2015 Jan-Mar;11(41):219-25. doi: 10.4103/0973-1296.149741.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk